The U.S. general Anesthesia drugs market is growing at a 2.6% CAGR (2025-2035), driven by rising surgeries, demand for IV ...
Baxter reported Q4 adjusted EPS of $0.58, beating the $0.52 consensus and its own guidance of $0.50-$0.53. Baxter forecasts 2025 sales growth of 5%-6% and adjusted EPS of $2.45-$2.55, with Q1 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results